- Home
- SMSI vs NVNO Comparison
SMSI vs NVNO Comparison
Compare SMSI & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- NVNO
- Stock Information
- Founded
- SMSI 1982
- NVNO 1987
- Country
- SMSI United States
- NVNO United States
- Employees
- SMSI N/A
- NVNO N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- NVNO Medical/Dental Instruments
- Sector
- SMSI Technology
- NVNO Health Care
- Exchange
- SMSI Nasdaq
- NVNO Nasdaq
- Market Cap
- SMSI 15.3M
- NVNO 16.7M
- IPO Year
- SMSI 1995
- NVNO N/A
- Fundamental
- Price
- SMSI $0.70
- NVNO $0.73
- Analyst Decision
- SMSI Strong Buy
- NVNO
- Analyst Count
- SMSI 1
- NVNO 0
- Target Price
- SMSI $5.00
- NVNO N/A
- AVG Volume (30 Days)
- SMSI 1.3M
- NVNO 331.1K
- Earning Date
- SMSI 11-12-2025
- NVNO 10-31-2025
- Dividend Yield
- SMSI N/A
- NVNO N/A
- EPS Growth
- SMSI N/A
- NVNO N/A
- EPS
- SMSI N/A
- NVNO N/A
- Revenue
- SMSI $18,658,000.00
- NVNO N/A
- Revenue This Year
- SMSI N/A
- NVNO N/A
- Revenue Next Year
- SMSI $59.48
- NVNO N/A
- P/E Ratio
- SMSI N/A
- NVNO N/A
- Revenue Growth
- SMSI N/A
- NVNO N/A
- 52 Week Low
- SMSI $0.60
- NVNO $0.67
- 52 Week High
- SMSI $1.95
- NVNO $5.62
- Technical
- Relative Strength Index (RSI)
- SMSI 43.39
- NVNO 32.52
- Support Level
- SMSI $0.69
- NVNO $0.68
- Resistance Level
- SMSI $0.74
- NVNO $0.76
- Average True Range (ATR)
- SMSI 0.05
- NVNO 0.06
- MACD
- SMSI -0.01
- NVNO 0.03
- Stochastic Oscillator
- SMSI 9.35
- NVNO 16.45
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.